ATE510025T1 - Verfahren für die detektion von mutationen in nukleinsaüren, und die anwendung in der diagnose von genetischen krankheiten und krebs - Google Patents

Verfahren für die detektion von mutationen in nukleinsaüren, und die anwendung in der diagnose von genetischen krankheiten und krebs

Info

Publication number
ATE510025T1
ATE510025T1 AT05027186T AT05027186T ATE510025T1 AT E510025 T1 ATE510025 T1 AT E510025T1 AT 05027186 T AT05027186 T AT 05027186T AT 05027186 T AT05027186 T AT 05027186T AT E510025 T1 ATE510025 T1 AT E510025T1
Authority
AT
Austria
Prior art keywords
nucleic acid
acid fragment
diagnosis
genetic diseases
cancer
Prior art date
Application number
AT05027186T
Other languages
English (en)
Inventor
Jean-Louis Viovy
Claude Houdayer
Dominique Stoppa-Lyonnet
Jeremie Weber
Original Assignee
Inst Curie
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Curie, Centre Nat Rech Scient filed Critical Inst Curie
Application granted granted Critical
Publication of ATE510025T1 publication Critical patent/ATE510025T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT05027186T 2005-12-13 2005-12-13 Verfahren für die detektion von mutationen in nukleinsaüren, und die anwendung in der diagnose von genetischen krankheiten und krebs ATE510025T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05027186A EP1798291B1 (de) 2005-12-13 2005-12-13 Verfahren für die Detektion von Mutationen in Nukleinsaüren, und die Anwendung in der Diagnose von genetischen Krankheiten und Krebs

Publications (1)

Publication Number Publication Date
ATE510025T1 true ATE510025T1 (de) 2011-06-15

Family

ID=36293478

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05027186T ATE510025T1 (de) 2005-12-13 2005-12-13 Verfahren für die detektion von mutationen in nukleinsaüren, und die anwendung in der diagnose von genetischen krankheiten und krebs

Country Status (5)

Country Link
US (1) US20070161032A1 (de)
EP (1) EP1798291B1 (de)
JP (1) JP2007202552A (de)
CN (1) CN1982477A (de)
AT (1) ATE510025T1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005061728A1 (en) * 2003-12-16 2005-07-07 Institut Curie Methods and compositions for assaying mutations in nucleic acids
WO2011101370A1 (en) * 2010-02-18 2011-08-25 F. Hoffmann-La Roche Ag Method for the determination of sequence variants of polypeptides
WO2017189677A1 (en) * 2016-04-27 2017-11-02 Arc Bio, Llc Machine learning techniques for analysis of structural variants
CN110982887A (zh) * 2019-12-30 2020-04-10 上海健康医学院 用于lkb1基因突变检测的引物及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885432A (en) * 1992-11-05 1999-03-23 Soane Biosciences Un-crosslinked polymeric media for electrophoresis
AU1254295A (en) 1993-12-17 1995-07-03 Perkin-Elmer Corporation, The Uncharged polymers for separation of biomolecules by capillary electrophoresis
US5994075A (en) * 1996-05-17 1999-11-30 Hexagen Technology Limited Methods for identifying a mutation in a gene of interest without a phenotypic guide
ATE428801T1 (de) * 1996-06-04 2009-05-15 Univ Utah Res Found Überwachung der hybridisierung während pcr
US20020169309A1 (en) * 1997-08-05 2002-11-14 Gjerde Douglas T. Mutation detection method
WO1999023257A1 (en) * 1997-10-31 1999-05-14 Transgenomic, Inc. Method of detecting mutant dna by mipc and pcr
CA2336546A1 (en) * 1998-08-19 2000-03-02 Vanderbilt University Method for determining polynucleotide sequence variations
CA2354322A1 (en) * 1998-12-09 2000-06-15 Massachusetts Institute Of Technology Methods of identifying point mutations in a genome
WO2001034839A1 (en) * 1999-11-12 2001-05-17 Dunlop Charles L M Approaches to identify genetic traits
FR2811083B1 (fr) 2000-06-30 2002-11-22 Inst Curie Milieu liquide non-thermosensible pour l'analyse d'especes au sein d'un canal
US20040018497A1 (en) * 2002-07-26 2004-01-29 Warden Craig H Human obesity LIPIN3 polynucleotide and polypeptide sequences and methods of use thereof

Also Published As

Publication number Publication date
CN1982477A (zh) 2007-06-20
JP2007202552A (ja) 2007-08-16
EP1798291A1 (de) 2007-06-20
US20070161032A1 (en) 2007-07-12
EP1798291B1 (de) 2011-05-18

Similar Documents

Publication Publication Date Title
Bellassai et al. Surface plasmon resonance for biomarker detection: advances in non-invasive cancer diagnosis
Chahine et al. Blood-based biomarkers for Parkinson's disease
Pedersen et al. Leukocyte DNA methylation signature differentiates pancreatic cancer patients from healthy controls
US7105293B2 (en) Genetic markers for tumors
JP7452894B2 (ja) 遺伝子のｃｐｇメチル化変化を用いた肝癌の予後または危険度を評価する方法
US8911940B2 (en) Methods of assessing a risk of cancer progression
WO2005103719A3 (en) Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies
WO2006080597A1 (en) Markers for the diagnosis of lung cancer
WO2009149297A1 (en) Diffuse large b-cell lymphoma markers and uses therefor
Kharati et al. Early diagnosis of multiple sclerosis based on optical and electrochemical biosensors: Comprehensive perspective
Wang et al. Circulating tumor DNA analysis for tumor diagnosis
KR101478826B1 (ko) 신규한 대장암 진단용 마커 및 이를 이용한 대장암 진단 키트
JP2013509169A (ja) 前立腺癌の診断および病期分類のための非侵襲的マーカーとなる血中ｍｉＲＮＡ
CN108504732A (zh) 一种建立胃癌的风险预测模型的方法
ATE510025T1 (de) Verfahren für die detektion von mutationen in nukleinsaüren, und die anwendung in der diagnose von genetischen krankheiten und krebs
CN107142320A (zh) 用于检测肝癌的基因标志物及其用途
EP2707505B1 (de) Spektralbildgebung zur messung von nuklearpathologischen merkmalen in krebszellen zur in-situ-analyse
Banks et al. Introduction to electrochemistry for health applications
WO2011146937A1 (en) Methods and kits useful in diagnosing nsclc
KR101604178B1 (ko) 약물에 의한 간 손상의 예측 및 진단을 위한 바이오마커
Kim et al. Sensitive detection of multiple fluoresence probes based on surface-enhanced raman scattering (sers) for mers-cov
Sultana et al. Quantitative analysis of serum cell-free DNA as a predictive and prognostic marker in breast cancer patients
US20030152972A1 (en) Gene expression associated with psychiatric disorders
Chandrasekaran et al. Detection of Alzheimer’s associated microRNAs using a DNA-based smart reagent
Ishwar et al. DNA Methylation Signatures of Tumor-Associated Natural Killer Cells with Self-Functionalized Nanosensor Enable Colorectal Cancer Diagnosis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties